Kilitch Drugs (India) Limited

NSE:KILITCH.NS

311.95 (INR) • At close November 4, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) INR.

2024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q22020 Q12019 Q42019 Q32019 Q22019 Q12018 Q42018 Q32018 Q22018 Q12014 Q42014 Q32014 Q22014 Q12013 Q42013 Q32013 Q22013 Q12012 Q42012 Q32012 Q22012 Q1
Revenue 334.516448.188317.945412.022365.57454.771299.723306.97334.527366.075344.313235.705196.249199.32203.274180.72101.917116.231159.299153.351104.319191.66584.173268.209280.85238.1436.08160.44855.60470.18813.11728.8136.86671.87334.48865.096154.319
Cost of Revenue 220.913280.569169.887202.055170.113255.458136.477154.029201.626204.813209.974129.614109.933114.192101.37585.27572.2361.62391.18573.65764.3999.07545.932165.451171.22337.28916.11615.28326.82566.5227.5117.8219.36370.65518.1356.186128.896
Gross Profit 113.603167.619148.058209.967195.457199.313163.246152.941132.901161.262134.339106.09186.31685.128101.89995.44529.68754.60868.11479.69439.92992.5938.241102.758109.6290.85119.96545.16528.7793.6665.60620.9917.5031.21816.3588.9125.423
Gross Profit Ratio 0.340.3740.4660.510.5350.4380.5450.4980.3970.4410.390.450.440.4270.5010.5280.2910.470.4280.520.3830.4830.4540.3830.390.0220.5530.7470.5180.0520.4270.7290.4750.0170.4740.1370.165
Reseach & Development Expenses 0000000000000000000000000000000000000
General & Administrative Expenses 0070.5870.80825.23453.9971.79261.89127.89416.35715.66915.70648.42543.83514.14913.22311.54615.25814.31313.98613.34452.13810.39114.54213.81612.1077.5948.367.89410.537000-59.59516.77723.02216.704
Selling & Marketing Expenses 0029.61126.84926.88654.28421.87620.76417.31613.33712.02215.19914.75524.5357.6177.6585.0226.0649.5518.59912.48816.46521.3224.2026.4068.0383.4812.4244.79226.18800012.666000
SG&A 105.525106.139100.19197.65752.12108.27493.66882.65545.2129.69427.69130.90563.1868.3721.76620.88116.56641.32223.86422.58525.83268.60331.71138.74420.22260.7511.07510.78412.68667.3317.1456.3436.08-57.72916.77723.02216.704
Other Expenses 25.7384.71229.5614.8915.62510.2046.8662.3969.714-22.6913.0911.68110.538-9.8013.6844.2213.695-24.8686.8975.86313.779-45.4563.27419.21623.76700000000132.72-6.764-12.483-20.351
Operating Expenses 105.525106.139133.407131.938141.565146.325132.715122.28106.928111.834128.69376.49981.7281.44176.71470.82845.66479.74258.7867.08751.60618.16279.00163.52682.25833.79129.10635.39826.04544.03411.03512.1630.81274.99110.01310.539-3.647
Operating Income 8.07861.4844.21282.9253.89263.19237.39733.05725.97360.3225.64629.59219.35128.22232.80232.275-10.957-10.95718.88521.2060.81190.893-19.4463.43433.777-10.279-16.1963.662-3.885-41.086-4.825-1.746-2.837-73.7736.345-1.62929.07
Operating Income Ratio 0.0240.1370.1390.2010.1470.1390.1250.1080.0780.1650.0160.1260.0990.1420.1610.179-0.108-0.0940.1190.1380.0080.474-0.2310.2370.12-0.27-0.4490.061-0.07-0.585-0.368-0.061-0.077-1.0260.184-0.0250.188
Total Other Income Expenses Net 8.423-8.511-15.987-15.089-9.369-12.07-12.885-17.5192.999-24.46710.7410.45-5.492-16.522-5.146-5.221-4.257-4.917-4.356-4.38-0.219-77.127-18.046-4.98617.361-2.5657.0556.1056.61915.69814.41810.57320.53478.62921.037-0.434-0.317
Income Before Tax 16.50152.96928.22567.83144.52351.12224.51215.53828.97235.85616.38730.04213.85911.727.65627.054-15.214-15.87414.52916.8260.59213.766-37.48658.44851.138-12.844-9.1419.7672.734-25.3889.5938.82717.6974.8566.345-2.06328.753
Income Before Tax Ratio 0.0490.1180.0890.1650.1220.1120.0820.0510.0870.0980.0480.1270.0710.0590.1360.15-0.149-0.1370.0910.110.0060.072-0.4450.2180.182-0.337-0.2530.1620.049-0.3620.7310.3060.480.0680.184-0.0320.186
Income Tax Expense 15.38216.16210.80916.89513.92822.117.431-3.82711.60212.85910.2584.2286.6634.6155.8174.975-1.877-3.4025.0793.4492.5278.80710.66916.37311.7190.8691.6383.5712.256.9341.514.2890-0.27121.0370.20
Net Income 13.40335.94229.09347.4133.57135.63423.70724.27820.86228.98111.24921.56511.8777.08622.14620.817-13.337-12.4729.4513.377-1.9354.959-48.15542.07539.419-13.713-7.50313.3384.984-18.4548.0834.53817.6975.1266.345-2.26328.753
Net Income Ratio 0.040.080.0920.1150.0920.0780.0790.0790.0620.0790.0330.0910.0610.0360.1090.115-0.131-0.1070.0590.087-0.0190.026-0.5720.1570.14-0.36-0.2080.2210.09-0.2630.6160.1580.480.0710.184-0.0350.186
EPS 0.832.241.812.952.152.291.521.561.341.860.721.390.760.461.431.34-0.86-0.810.620.87-0.130.32-3.333.012.57-1.03-0.571.010.38-1.390.610.341.310.330.48-0.182.17
EPS Diluted 0.832.241.812.952.152.291.521.561.341.860.721.390.760.461.431.34-0.86-0.80.620.87-0.130.32-3.333.012.57-1.03-0.571.010.38-1.390.610.341.310.330.48-0.171.98
EBITDA 16.58970.77152.3691.08667.40872.33546.66841.92343.91454.25320.70338.25319.57518.35133.88133.796-7.427-8.32822.10722.9786.46538.288-32.26263.49755.857-5.746-12.7867.073-0.475-37.487-1.8671.2120.1216.5099.6281.75132.45
EBITDA Ratio 0.050.1580.1650.2210.1840.1590.1560.1370.1310.1480.060.1620.10.0920.1670.187-0.073-0.0720.1390.150.0620.2-0.3830.2370.199-0.151-0.3540.117-0.009-0.534-0.1420.0420.0030.0910.2790.0270.21